Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma
Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma - OncoDaily
Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma / Angiosarcoma, Bella Hadid,
oncodaily.com
November 30, 2024 at 9:29 PM
Remembering Virgil Abloh: Louis Vuitton’s Creative Director Honored at 41 After His Brave Battle with Cardiac Angiosarcoma
Met a lovely woman last week with angiosarcoma of the heart. Her doc at MD Anderson couldn't get her a full course of ifosfamide, 1 of the few drugs indicated for soft tissue sarcomas.
September 24, 2026 at 1:37 AM
Met a lovely woman last week with angiosarcoma of the heart. Her doc at MD Anderson couldn't get her a full course of ifosfamide, 1 of the few drugs indicated for soft tissue sarcomas.
#Pathology - cardiac angiosarcoma w/ right atrial mass & localized mets in epicardium 🫀
#cardiosky
#medsky
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@danielvargasmd.bsky.social
@minipakkal.bsky.social
@katehanneman.bsky.social
#cardiosky
#medsky
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@danielvargasmd.bsky.social
@minipakkal.bsky.social
@katehanneman.bsky.social
December 18, 2024 at 4:27 PM
#Pathology - cardiac angiosarcoma w/ right atrial mass & localized mets in epicardium 🫀
#cardiosky
#medsky
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@danielvargasmd.bsky.social
@minipakkal.bsky.social
@katehanneman.bsky.social
#cardiosky
#medsky
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@danielvargasmd.bsky.social
@minipakkal.bsky.social
@katehanneman.bsky.social
Vi ricordate di lei? È Sofia Sacchitelli, scomparsa a 23 anni, al quinto anno di Medicina, per un angiosarcoma cardiaco nel 2023.
Ciao Sofìa, coraggiosa e splendida Collega.
Ciao Sofìa, coraggiosa e splendida Collega.
September 12, 2026 at 8:31 PM
Vi ricordate di lei? È Sofia Sacchitelli, scomparsa a 23 anni, al quinto anno di Medicina, per un angiosarcoma cardiaco nel 2023.
Ciao Sofìa, coraggiosa e splendida Collega.
Ciao Sofìa, coraggiosa e splendida Collega.
#PathSky. As long as I’m sitting here in Sunday doing a frozen….
73F, arm. Foamy cell angiosarcoma- a very difficult, very rare subtype.
pubmed.ncbi.nlm.nih.gov/20175826/
73F, arm. Foamy cell angiosarcoma- a very difficult, very rare subtype.
pubmed.ncbi.nlm.nih.gov/20175826/
November 24, 2024 at 8:29 PM
#PathSky. As long as I’m sitting here in Sunday doing a frozen….
73F, arm. Foamy cell angiosarcoma- a very difficult, very rare subtype.
pubmed.ncbi.nlm.nih.gov/20175826/
73F, arm. Foamy cell angiosarcoma- a very difficult, very rare subtype.
pubmed.ncbi.nlm.nih.gov/20175826/
Anyway, welcome to our newest episode of "Is it my current chronic illnesses, or is it cancer."
For those of you just tuning in, I already spent five+ years diagnosed with fake angiosarcoma, so at this point it's hard to take anything seriously.
For those of you just tuning in, I already spent five+ years diagnosed with fake angiosarcoma, so at this point it's hard to take anything seriously.
August 7, 2026 at 11:48 PM
Anyway, welcome to our newest episode of "Is it my current chronic illnesses, or is it cancer."
For those of you just tuning in, I already spent five+ years diagnosed with fake angiosarcoma, so at this point it's hard to take anything seriously.
For those of you just tuning in, I already spent five+ years diagnosed with fake angiosarcoma, so at this point it's hard to take anything seriously.
#Pathology - cardiac angiosarcoma w/ right atrial mass & localize mets in epicardium 🫀 Cr. #OGdukeneurosurg
#cardiosky
@jasonnjohnson.bsky.social
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@lameliav.bsky.social
#cardiosky
@jasonnjohnson.bsky.social
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@lameliav.bsky.social
August 15, 2025 at 7:39 PM
#Pathology - cardiac angiosarcoma w/ right atrial mass & localize mets in epicardium 🫀 Cr. #OGdukeneurosurg
#cardiosky
@jasonnjohnson.bsky.social
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@lameliav.bsky.social
#cardiosky
@jasonnjohnson.bsky.social
@ericatirr.bsky.social
@drmonikaradike.bsky.social
@lameliav.bsky.social
#Pathology - cardiac angiosarcoma w/ right atrial mass & localize mets in epicardium 🫀
@smlungpathguy.bsky.social
@smlungpathguy.bsky.social
June 29, 2026 at 10:49 PM
#Pathology - cardiac angiosarcoma w/ right atrial mass & localize mets in epicardium 🫀
@smlungpathguy.bsky.social
@smlungpathguy.bsky.social
Less than a year ago, he was found in complete heart failure and life-flighted to Boston Children's Hospital, later diagnosed with angiosarcoma, a rare and aggressive type of cancer. After 6 rounds of chemotherapy, Riley is in remission and back on the pitcher's mound, playing the game he loves 💛
July 22, 2025 at 10:48 PM
Less than a year ago, he was found in complete heart failure and life-flighted to Boston Children's Hospital, later diagnosed with angiosarcoma, a rare and aggressive type of cancer. After 6 rounds of chemotherapy, Riley is in remission and back on the pitcher's mound, playing the game he loves 💛
for those of you who have not been along for the journey... it was weird, because my body is weird. I was diagnosed with angiosarcoma, which it definitely wasn't, because I'm not dead. For a bunch of years I was a cancer patient with no symptoms, & every 2-4 months we checked to see if I was dying.
November 25, 2025 at 4:14 AM
for those of you who have not been along for the journey... it was weird, because my body is weird. I was diagnosed with angiosarcoma, which it definitely wasn't, because I'm not dead. For a bunch of years I was a cancer patient with no symptoms, & every 2-4 months we checked to see if I was dying.
Today, we honored the life of the ethereal Allyce Trapp Alexander.
She was everything you could want in a friend. She deserved the world, not angiosarcoma — but she fought so valiantly for the last 16 months.
Team Allyce. Forever & always.
We will miss you, pretty lady.💛💜
She was everything you could want in a friend. She deserved the world, not angiosarcoma — but she fought so valiantly for the last 16 months.
Team Allyce. Forever & always.
We will miss you, pretty lady.💛💜
October 4, 2025 at 12:54 AM
Today, we honored the life of the ethereal Allyce Trapp Alexander.
She was everything you could want in a friend. She deserved the world, not angiosarcoma — but she fought so valiantly for the last 16 months.
Team Allyce. Forever & always.
We will miss you, pretty lady.💛💜
She was everything you could want in a friend. She deserved the world, not angiosarcoma — but she fought so valiantly for the last 16 months.
Team Allyce. Forever & always.
We will miss you, pretty lady.💛💜
my dad has been fighting some particularly aggressive angiosarcoma cancer for the past year. today he finished the fight.
sometimes winning is going out on your terms.
sometimes winning is going out on your terms.
January 19, 2026 at 11:04 PM
my dad has been fighting some particularly aggressive angiosarcoma cancer for the past year. today he finished the fight.
sometimes winning is going out on your terms.
sometimes winning is going out on your terms.
Epithelioid angiosarcoma with extensive intravascular growth. Obviously there must be a right sided primary. There’s supposed to be a liver mass.
June 5, 2025 at 7:20 PM
Epithelioid angiosarcoma with extensive intravascular growth. Obviously there must be a right sided primary. There’s supposed to be a liver mass.
Regina Henneman was diagnosed with angiosarcoma and was treated at Northwestern Medicine St. George Cancer Institute in Orland Park.
Mokena woman loving life after repeated battles with rare cancer
www.chicagotribune.com
August 14, 2026 at 7:51 PM
Regina Henneman was diagnosed with angiosarcoma and was treated at Northwestern Medicine St. George Cancer Institute in Orland Park.
Please, #pathsky community, confirm, that I'm not the only pathologist who never heard of foamy cell angiosarcoma...
#PathSky. As long as I’m sitting here in Sunday doing a frozen….
73F, arm. Foamy cell angiosarcoma- a very difficult, very rare subtype.
pubmed.ncbi.nlm.nih.gov/20175826/
73F, arm. Foamy cell angiosarcoma- a very difficult, very rare subtype.
pubmed.ncbi.nlm.nih.gov/20175826/
November 24, 2024 at 9:55 PM
Please, #pathsky community, confirm, that I'm not the only pathologist who never heard of foamy cell angiosarcoma...
This time, it *could* be something terrible or it could (again) be a radiologist who didn't read my (to be fair extensive and complicated) chart, and saw my WEIRD AS FUCK pelvis built of pig cadaver and bone growth goo, a past (incorrect) angiosarcoma diagnosis, and freaked.
August 11, 2026 at 5:18 PM
This time, it *could* be something terrible or it could (again) be a radiologist who didn't read my (to be fair extensive and complicated) chart, and saw my WEIRD AS FUCK pelvis built of pig cadaver and bone growth goo, a past (incorrect) angiosarcoma diagnosis, and freaked.
Today is World Cancer day and as a survivor of angiosarcoma I appreciate all cancer research. I guess the current administration would turn back the clock on cancer treatments if they could inflict a little more pain on people who least need it.
February 4, 2025 at 8:46 PM
Today is World Cancer day and as a survivor of angiosarcoma I appreciate all cancer research. I guess the current administration would turn back the clock on cancer treatments if they could inflict a little more pain on people who least need it.
March 19, 2025 at 9:11 PM
#PathSky 67F, s/p lumpectomy and RT 5 yrs ago for DCIS, now with a mass IN the breast. The outside was worried about post RT angiosarcoma, in part because of the CD31 and C-MYC. This is just fat necrosis with CD31-pos macrophages. 1- post RTAS occurs in the SKIN, not breast. 2- macs express CD31.
December 27, 2024 at 6:38 PM
#PathSky 67F, s/p lumpectomy and RT 5 yrs ago for DCIS, now with a mass IN the breast. The outside was worried about post RT angiosarcoma, in part because of the CD31 and C-MYC. This is just fat necrosis with CD31-pos macrophages. 1- post RTAS occurs in the SKIN, not breast. 2- macs express CD31.
I'm super looking forward to talking to my rheumatologist today who surely looked at my file this morning & is like "WTF is happening" (my GP sent me for the most recent scans because the misdiagnosed murder cancer lump has regrown - after more than a decade. It is clearly not angiosarcoma).
August 11, 2026 at 5:23 PM
I'm super looking forward to talking to my rheumatologist today who surely looked at my file this morning & is like "WTF is happening" (my GP sent me for the most recent scans because the misdiagnosed murder cancer lump has regrown - after more than a decade. It is clearly not angiosarcoma).
I had my thyroids partially removed over angiosarcoma.
The journey sucked.
The journey sucked.
September 1, 2026 at 5:10 PM
I had my thyroids partially removed over angiosarcoma.
The journey sucked.
The journey sucked.
Hi world! 🦋 I’m an Angiosarcoma cancer surviving, hEDS/POTS/MCAS fighting, ambulatory ♿️, progressive, witchy, 🏳️🌈 baddie who is adamantly opposed to all facists. I advocate fighting for human rights, climate justice, bodily autonomy, BLM, LGBTQ+ & disability rights. You are safe with me.🌻🫶🏳️🌈🍉
November 17, 2024 at 4:41 PM
Hi world! 🦋 I’m an Angiosarcoma cancer surviving, hEDS/POTS/MCAS fighting, ambulatory ♿️, progressive, witchy, 🏳️🌈 baddie who is adamantly opposed to all facists. I advocate fighting for human rights, climate justice, bodily autonomy, BLM, LGBTQ+ & disability rights. You are safe with me.🌻🫶🏳️🌈🍉
New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas
oncodaily.com/oncolibrary/...
#10MostPromisingCancerDrugs #Agenus #Angiosarcoma #ASCO #Botensilimab #CancerCare #CancerResearch #Immunotherapy #Sarcoma #SarcomaResearch #Health #Medicine #NewPaperAlert
oncodaily.com/oncolibrary/...
#10MostPromisingCancerDrugs #Agenus #Angiosarcoma #ASCO #Botensilimab #CancerCare #CancerResearch #Immunotherapy #Sarcoma #SarcomaResearch #Health #Medicine #NewPaperAlert
New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas - OncoDaily
Learn how a novel combination of Botensilimab and Balstilimab demonstrates promising efficacy in traditionally immunotherapy-resistant sarcomas.
oncodaily.com
January 28, 2025 at 8:56 PM
New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas
oncodaily.com/oncolibrary/...
#10MostPromisingCancerDrugs #Agenus #Angiosarcoma #ASCO #Botensilimab #CancerCare #CancerResearch #Immunotherapy #Sarcoma #SarcomaResearch #Health #Medicine #NewPaperAlert
oncodaily.com/oncolibrary/...
#10MostPromisingCancerDrugs #Agenus #Angiosarcoma #ASCO #Botensilimab #CancerCare #CancerResearch #Immunotherapy #Sarcoma #SarcomaResearch #Health #Medicine #NewPaperAlert